Drug Discovery News
-
Boehringer to open $46 mn biologics plant in Shanghai
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2013
Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer co...Read more
-
Recycled plastic can kill drug-resistant fungi
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2013
Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research...Read more
-
Novartis liver cancer trial with Afinitor flops
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2013
Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...Read more
-
Oramed submits pre-IND for exenatide to FDA
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 02 Aug, 2013
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...Read more
-
Aussie drug delivery firm raises $19.3 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to...Read more
-
Bayer initiates Phase II/III trial of a new compound for Hemophilia A
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to eval...Read more
-
APAC ovarian cancer drug market to grow modestly'
Drug Discovery | Analysis | By BioSpectrum Bureau | 2 Comment | 30 Jan, 2015
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...Read more
-
Deal with Janssen gets Astellas $65 million up-front
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2012
Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...Read more
-
Lorcaserin receives positive vote from FDA advisory committee
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...Read more
-
Biodiem gets US patent allowance for antifungal therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowanc...Read more
-
Minoryx Therapeutics receives Orphan Drug Designation for its lead candidate MIN-102
Drug Discovery | News | 0 Comment | 22 Feb, 2017
Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan di...Read more
-
Apollo Therapeutics launched the first drug discovery programme
Drug Discovery | News | 0 Comment | 22 Feb, 2017
Apollo Therapeutics, the collaborative venture between three world-leading UK universities and three global pharmaceutic...Read more
-
New CoolPal Vertos Advance launched by Pelican BioThermal
Drug Discovery | News | 0 Comment | 19 Jan, 2017
US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...Read more
-
Drug Discovery | News | 0 Comment | 19 Jan, 2017
Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...Read more
